Effects of the alpha- and gamma-polymorphs of glycine on the behavior of catalepsy prone rats

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 2, 2011, Pages 234-240

  Markel, Arcady L ^a,b   Achkasov, Andrey F ^b   Alekhina, Tatiana A ^a   Prokudina, Olga I ^a,b   Ryazanova, Marina A ^a   Ukolova, Tatiana N ^a   Efimov, Vadim M ^a,d   Boldyreva, Elena V ^b,c   Boldyrev, Vladimir V ^b,c  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

^c INSTITUTE OF SOLID STATE CHEMISTRY AND MECHANOCHEMISTRY   (Russian Federation)

^d TOMSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Anxiety; Behavior; Catalepsy; GC rat strain; Glycine polymorphs

Indexed keywords

ALPHA GLYCINE; AMINO ACID; GAMMA GLYCINE; GLYCINE; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CATALEPSY; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; EXPERIMENTAL TEST; EXPLORATORY BEHAVIOR; LIGHT DARK BOX TEST; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; BEHAVIOR, ANIMAL; CATALEPSY; CRYSTALLIZATION; DISEASE MODELS, ANIMAL; GLYCINE; MALE; MAZE LEARNING; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

RATTUS;

EID: 79251554376     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.12.025     Document Type: Article

References (57)

1. J. Archer Tests for emotionality in rats and mice: a review Anim Behav 21 1973 205 235
2. D. Babić, and R. Babić Complementary and alternative medicine in the treatment of schizophrenia Psychiatr Danub 21 2009 376 381
3. N.N. Barykina, I.L. Chepkasov, T.A. Alekhina, and V.G. Kolpakov Breeding of Wistar rats for predisposition to catalepsy Genetika 19 1983 2014 2021 Russian. (Pubitemid 14187896)
4. J. Bernstein Polymorphism in molecular crystals. IUCr monographs on crystallography 2002 Clarendon Press Oxford
5. E.V. Boldyreva, V.A. Drebuhchak, T.N. Drebushchak, I.E. Paukov, YuA Kovalevskaya, and E.S. Shutova Polymorphism of glycine: thermodynamic aspects. 1. Relative stability of the polymorphs J Therm Anal Calorim 73 Pharma Issue 2003 409 418
6. E.V. Boldyreva, V.A. Drebushchak, T.N. Drebushchak, I.E. Paukov, YuA Kovalevskaya, and E.S. Shutova Polymorphism of glycine: thermodynamic aspects. 2. Polymorphic transformations J Therm Anal Calorim 73 Pharma Issue 2003 419 428
7. E.V. Boldyreva Combined X-ray diffraction and Raman spectroscopy studies of phase transitions in crystalline amino acids at low temperatures and high pressures. Selected examples Phase Transitions 82 2009 303 321
8. E.V. Boldyreva Crystalline amino acids - a link between chemistry, materials science and biology J.C.A. Boeyens, J.F. Ogilvie, Models, mysteries, and magic of molecules 2007 Springer Netherlands Dordrecht 169 194
9. H.N. Bordallo, E.V. Boldyreva, A. Buchsteiner, M.M. Koza, and S. Landsgesell Dynamic properties of the polymorphs of glycine: an incoherent inelastic neutron scattering study J Phys Chem B 112 2008 8748 8759
10. J.A. Bouwknecht, and R. Paylor Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behavior in rodents Behav Pharmacol 19 2008 385 402
11. H.G. Brittain Polymorphism in pharmaceutical solids 1999 Marcel Dekker New York
12. P.L. Broadhurst Determinants of emotionality in the rat: I. Situational factors Br J Psychol 48 1957 1 12
13. P.W. Carter, A.C. Hillier, and M.D. Ward Nanoscale surface topography and growth of molecular crystals: the role of anisotropic intermolecular bonding J Am Chem Soc 116 1994 944 953 (Pubitemid 24980539)
14. S. Chattopadhyay, D. Erdemir, J.M.B. Evans, J. Ilavsky, H. Amenitsch, C.U. Segre, and A.S. Myerson SAXS study of the nucleation of glycine crystals from a supersaturated solution Cryst Growth Des 5 2005 523 527 (Pubitemid 40476626)
15. B.M. Cortese, and K.L. Phan The role of glutamate in anxiety and related disorders CNS Spectr 10 10 2005 820 830 (Pubitemid 41531936)
16. J.T. Coyle, and G. Tsai The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia Psychopharmacology 174 2004 32 38 (Pubitemid 38925088)
17. J.N. Crawley, and F.K. Goodwin Neuropharmacologic specificity of a simple animal model for the behavioural actions of benzodiazepines Pharmacol Biochem Behav 15 1981 695 699 (Pubitemid 12195249)
18. M. Davis, D. Rainnie, and M. Cassell Neurotransmission in the rat amygdala related to fear and anxiety Trends Neurosci 17 5 1994 208 214 (Pubitemid 24128464)
19. D. Erdimir, S. Chattopadhyay, L. Guo, J. Ilavsky, H. Amenitsch, C.U. Segre, and A.S. Myerson Relationship between self-association of glycine molecules in supersaturated solutions and solid state outcome Phys Rev Lett 99 2007 115702
20. C. Fernandes, and S.E. File The influence of open arm ledges and maze experience in the elevated plus-maze Pharmacol Biochem Behav 54 1996 31 40 (Pubitemid 26143090)
21. S.E. File Factors controlling measures of anxiety and responses to novelty in the mouse Behav Brain Res 125 2001 151 157 (Pubitemid 33000453)
22. D. Gidalevitz, R. Feidenhansl, S. Matlis, D.-M. Smilgies, M.J. Christensen, and L. Leiserowitz Monitoring in situ growth and dissolution of molecular crystals: towards determination of the growth units Angew Chem Int Ed Engl 36 1997 955 959
23. D.C. Goff, and J.T. Coyle The emerging role of glutamate in the pathophysiology and treatment of schizophrenia Am J Psychiatry 158 2001 1367 1377 (Pubitemid 32847232)
24. E.I. Gusev, I.A. Komissarova, V.V. Alferova, and YaR Nartsissov An experience of applying a metabolite complex Glycine®, Biotredine®, Limontar® for therapy of acute ischaemic stroke Terra Med 4 2001 37 38 Russian
25. E.I. Gusev, V.I. Skvortsova, S.A. Dambinova, K.S. Raevskiy, A.A. Alekseev, V.G. Bashkatova, A.V. Kovalenko, V.S. Kudrin, and E.V. Yakovleva Neuroprotective effects of glycine for therapy of acute ischaemic stroke Cerebrovasc Dis 10 2000 49 60 (Pubitemid 30034858)
26. E.I. Gusev, V.I. Skvortsova, I.A. Komissarova, S.A. Dambinova, K.S. Raevsky, A.A. Alekseev, V.G. Bashkatova, A.V. Kovalenko, V.S. Kudrin, and E.V. Yakovleva Neuroprotective effect of glycine in the acute period of ischemic stroke Zh Nevropatol Psikhiatr Im S S Korsakova 99 1999 12 20 Russian
27. C.S. Hall Emotional behaviour in the rats: defecation and urination as measures of individual differences in emotionality J Comp Psychol 18 1934 385 403
28. U. Heresco-Levy, D.C. Javitt, M. Ermilov, C. Mordel, G. Silipo, and M. Lichtenstein Efficacy of highdose glycine in the treatment of enduring negative symptoms of schizophrenia Arch Gen Psychiatry 56 1999 29 36 (Pubitemid 29055047)
29. R. Hilfiker Polymorphism in the pharmaceutical industry 2006 Wiley-VCH Weinheim
30. J. Hons, R. Zirko, M. Ulrychova, E. Cermakova, P. Doubek, and J. Libiger Glycine serum level in schizophrenia: relation to negative symptoms Psychiatry Res 176 2010 103 108
31. C.E. Hughes, S. Hamad, K.D.M. Harris, C.R.A. Catlow, and P.C. Griffiths Faraday Discuss 36 2007 71 89
32. Y. Iitaka The crystal structure of β-glycine Acta Crystallogr 13 1960 35 45
33. Y. Iitaka The crystal structure of γ-glycine Acta Crystallogr 14 1961 1 10
34. D.C. Javitt, I. Zylberman, S.R. Zukin, U. Heresco-Levy, and J.-P. Lindenmayer Amelioration of negative symptoms in schizophrenia by glycine Am J Psychiatry 151 1994 1234 1236 (Pubitemid 24240973)
35. M.J. Kaufman, A.P. Prescot, D. Ongur, A.E. Evins, T.L. Barros, and C.L. Medeiros Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study Psychiatry Res 173 2009 143 149
36. V.G. Kolpakov, N.N. Barykina, T.A. Alekhina, and IYu Ponomarev Some genetic animal models for comparative psychology and biological psychiatry 1996 the Institute of Cytology & Genetics, Siberian Branch of the Russian Acad. Sci Novosibirsk
37. V.G. Kolpakov, N.N. Barykina, V.F. Chugui, and T.A. Alekhina Relationship between some forms of catalepsy in rats: an attempt of genetic analysis Genetika 35 1999 685 688 Russian (Pubitemid 129606257)
38. V.G. Kolpakov, A.V. Kulikov, T.A. Alekhina, V.F. Chuguy, O.I. Petrenko, and N.N. Barykina Catatonia or depression: the GC rat strain as an animal model of psychopathology Genetika 40 2004 672 678 Russian (Pubitemid 41071238)
39. V.G. Kolpakov, E.M. Nikulina, T.A. Alekhina, and M.M. Geworgian Effect of neuroleptics on various kinds of catalepsy in rats with genetic predisposition to catatonic reactions Zh Vyssh Nerv Deiat Im I P Pavlova 45 1995 388 394 Russian
40. I.A. Komissarova, and YaR Nartsissov Molecular mechanisms of the therapeutic action of glycine Terra Med 1 2001 23 25 Russian
41. S.M. Korte, and S.F. De Boer A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze Eur J Pharmacol 463 1-3 2003 163 175 (Pubitemid 36205078)
42. B. Laube, H. Hirai, M. Sturgess, H. Betz, and J. Kuhse Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit Neuron 18 1997 493 503 (Pubitemid 27138796)
43. T. Lipina, V. Labrie, I. Weiner, and J. Roder Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia Psychopharmacology 179 2005 54 67 (Pubitemid 40576692)
44. G.J. Marek, B. Behl, A.Y. Bespalov, G. Gross, Y. Lee, and H. Schoemaker Glutamatergic (N-methyl-d-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? Mol Pharmacol 77 2010 317 326
45. A.L. Markel, YuK Galaktionov, and V.M. Efimov Factor analysis of rat behavior in an open field test Neurosci Behav Physiol 19 4 1989 279 286
46. R.E. Marsh A refinement of the crystal structure of glycine Acta Crystallogr 11 1958 654 663
47. K. Padilla-Martin, B. Baltazar-Rendon, A. Gonzalez-Maciel, A. Nuño-Licona, R. Uribe-Escamilla, A. Hernandez-Romero, A. Ramos, and A. Alfaro-Rodriguez Effects of glycine on electrical and histological properties of a rat peripheral nerve injury model Ulus Travma Acil Cerrahi Derg 15 2009 103 108
48. E.V. Petrova The characteristics of a change in the congenital and acquired forms of behavior in rats with genetic catalepsy Zh Vyssh Nerv Deiat Im I P Pavlova 40 3 1990 475 480 Russian
49. I.Z. Pliusnina, L.N. Trut, N.I. Karpushkeeva, T.A. Alekhina, and I.N. Oskina Behavioral and physiological characteristics of nonagouti mutation in gray rats during selection for aggressiveness Zh Vyssh Nerv Deiat Im I P Pavlova 53 6 2003 730 738 Russian
50. R.J. Rodgers, and J.C. Cole The elevated plus-maze: pharmacology, methodology and ethology S.J. Cooper, C.A. Hendrie, Ethology and psychopharmacology 1994 Wiley Chichester 9 44
51. T.P. Shakhtshneider, and V.V. Boldyrev Mechanochemical synthesis and mechanical activation of drugs E.V. Boldyreva, V.V. Boldyrev, Reactivity of molecular solids, molecular solid state series 1999 Wiley Chichester 271 311
52. T. Shimazaki, A. Kaku, and S. Chaki d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats Psychopharmacology 209 2010 263 270
53. Smith, C.U. Elements of molecular neurobiology. London, 1996. 522 p.
54. M.-J. Tsai, Y.-B. Huang, and P.-C. Wu Monitoring amino acid neurotransmitters in plasma profiles and predicting early progression of ischemic stroke Chin Pharm J 54 2002 215 224
55. D.L. Walker, K.J. Ressler, K.-T. Lu, and M. Davis Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats J Neurosci 22 2002 2343 2351 (Pubitemid 35386533)
56. R. Waziri Glycine therapy of schizophrenia: some caveats Biol Psychiatry 39 1996 155 156 (Pubitemid 26072711)
57. X. Yang, X. Wang, and C.B. Ching Solubility of α-form and γ-form of glycine in aqueous solutions J Chem Eng Data 53 2008 1133 1137